Additional Ventures funds research to cure single ventricle heart disease through a portfolio of award programs, including the Single Ventricle Research Fund, an Expansion Award for high-risk novel ideas, and a postdoctoral fellowship co-funded with the Life Sciences Research Foundation for researchers within five years of their Ph.D. or M.D. Programs welcome both new and established investigators to the single ventricle field.